OSF Healthcare System
VC Fund
Peoria, United States
OSF Healthcare System is a VC fund in Peoria focused on Health Care and Medical. OSF HealthCare is an integrated health care network serving the patients and families of central and northern Illinois and northern Michigan.OSF HealthCare, owned and operated by The Sisters of the Third Order of St. Francis, Peoria, Illinois, includes OSF Healthcare System consisting of eight acute care facilities and two colleges of nursing.It also has a primary care physician network consisting of over 600 primary care, specialist physicians, and advanced practice providers.OSF HealthCare owns OSF Saint Francis, Inc., comprised of health care-related businesses, and OSF Healthcare Foundation, the philanthropic arm of OSF Healthcare System and OSF Home Care Services.OSF HealthCare is a multi-state corporation, operating facilities in Illinois and Michigan, providing state-of-the-art, compassionate care to more than 2.5 million people in the communities they serve.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $75M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries OSF Healthcare System invests in
Stages OSF Healthcare System invests in
Countries OSF Healthcare System invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Michelle Carrothers
|
|||
Stan Lynall
|
|||
|
Andrea Brandon
|
|||
Mark Plunkett
|
|||
Investment Focus
Industry
- Health Care 11 (58%)
- Medical 5 (26%)
- Medical Device 5 (26%)
- Machine Learning 3 (16%)
- Hospital 2 (11%)
Stage
- Series B 7 (37%)
- Series A 3 (16%)
- Series C 2 (11%)
- Series E 2 (11%)
- Venture - Series Unknown 2 (11%)
Country
- United States 13 (68%)
- Israel 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Michelle Carrothers
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
|
Stan Lynall
Vice President of Venture Investments
|
Vice President of Venture Investments | Total investments: 8 | Find email | |
|
Andrea Brandon
Marketing & Communications Director, Western Region
|
Marketing & Communications Director, Western Region | Total investments: 0 | Find email | |
|
Mark Plunkett
MD
|
MD | Total investments: 0 | Find email | |
Robert Sehring
CEO - Ambulatory Services
|
CEO - Ambulatory Services | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $12M / Venture - Series Unknown / Jul 14, 2026 | |
Monteris Medical
|
Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $28M / Series E / Mar 12, 2026 | |
|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $14M / Series B / Mar 17, 2025 | |
TailorMed
|
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $27.5M / Series B / Nov 21, 2024 | |
Inflammatix
|
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges.They are initially focused on developing tests for acute bacterial andviral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. | $57M / Series E / Sep 12, 2024 | |
Pieces
|
Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services. Our solution interprets patient information in real-time and connects health systems and community-basedorganizations to support healthier outcomes, both inside and outside of hospital walls. Using cloud-based artificial intelligence with clinically-based natural language processing (NLP) and physician-supervised machine learning, our tools help streamline clinician workflows and improve patient outcomes. Combined, our solutions, Pieces Predict and Pieces Connect, create a comprehensive and unique solution for connected community health. | $25M / Venture - Series Unknown / Sep 10, 2024 | |
|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $7.5M / Series B / May 25, 2023 | |
Array Behavioral Care
|
Array Behavioral Care telepsychiatry service provider with a mission to transform access to quality and timely behavioral health care. | $25M / Series C / Jan 09, 2023 | |
Socially Determined
|
Socially Determined identifies social risks and provides insights to prevent workplace social determinants of health (SDOH) with their software.Through Socialy Determined's software, theyr social risk intelligence platform informs the clients' organization's intervention strategies to identify the social risk drivers affecting theworkplace.Socially Determined was established on January 22, 2017 by Trenor Williams, and Ryan Bosch in Washington, DC. | $22.7M / Series B / May 31, 2022 | |
Exela Pharma Sciences
|
Exela Pharma Sciences, LLC is a fast-growing US-based integrated specialty pharmaceutical company, that develops, manufactures, and markets proprietary and generic sterile injectable products with the healthcare provider and patient in mind. We are passionate about alleviating or eliminating drug shortages. Exela receives awards for its supplychain commitment and dedication to creating hundreds of high-value jobs in rural America. | Corporate Round / Sep 08, 2021 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does OSF Healthcare System invest in?
OSF Healthcare System invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Series A stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact OSF Healthcare System?
Public channels for OSF Healthcare System include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at OSF Healthcare System?
The team at OSF Healthcare System includes Michelle Carrothers (Executive Director), Stan Lynall (Vice President of Venture Investments) and Andrea Brandon (Marketing & Communications Director, Western Region). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
